These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8763337)

  • 1. Glutathione and related enzymes in multidrug resistance.
    O'Brien ML; Tew KD
    Eur J Cancer; 1996 Jun; 32A(6):967-78. PubMed ID: 8763337
    [No Abstract]   [Full Text] [Related]  

  • 2. Glutathione transferases and development of new principles to overcome drug resistance.
    Sau A; Pellizzari Tregno F; Valentino F; Federici G; Caccuri AM
    Arch Biochem Biophys; 2010 Aug; 500(2):116-22. PubMed ID: 20494652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major vault protein LRP-related multidrug resistance.
    Izquierdo MA; Scheffer GL; Flens MJ; Schroeijers AB; van der Valk P; Scheper RJ
    Eur J Cancer; 1996 Jun; 32A(6):979-84. PubMed ID: 8763338
    [No Abstract]   [Full Text] [Related]  

  • 4. [Proteins in cancer multidrug resistance].
    Popęda M; Płuciennik E; Bednarek AK
    Postepy Hig Med Dosw (Online); 2014 May; 68():616-32. PubMed ID: 24864112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug resistance reversal in childhood malignancies--potential for a real step forward?
    Pinkerton CR
    Eur J Cancer; 1996 Apr; 32A(4):641-4. PubMed ID: 8695268
    [No Abstract]   [Full Text] [Related]  

  • 6. [Multidrug resistance in the treatment of cancer].
    Kuitunen T; Pyrhönen S
    Duodecim; 1991; 107(22):1846-51. PubMed ID: 1365962
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of glutathione, glutathione S-transferases and multidrug resistance-related proteins in cisplatin sensitivity of head and neck cancer cell lines.
    Welters MJ; Fichtinger-Schepman AM; Baan RA; Flens MJ; Scheper RJ; Braakhuis BJ
    Br J Cancer; 1998 Feb; 77(4):556-61. PubMed ID: 9484811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrins and extracellular matrix: a novel mechanism of multidrug resistance.
    Elliott T; Sethi T
    Expert Rev Anticancer Ther; 2002 Aug; 2(4):449-59. PubMed ID: 12647988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: How does the MRP/GS-X pump export doxorubicin?
    Broxterman HJ; Heijn M; Lankelma J
    J Natl Cancer Inst; 1996 Apr; 88(7):466-8. PubMed ID: 8618244
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological considerations in the modulation of multidrug resistance.
    Fisher GA; Lum BL; Hausdorff J; Sikic BI
    Eur J Cancer; 1996 Jun; 32A(6):1082-8. PubMed ID: 8763350
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined action and regulation of phase II enzymes and multidrug resistance proteins in multidrug resistance in cancer.
    Meijerman I; Beijnen JH; Schellens JH
    Cancer Treat Rev; 2008 Oct; 34(6):505-20. PubMed ID: 18413281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biology of the multidrug resistance-associated protein, MRP.
    Loe DW; Deeley RG; Cole SP
    Eur J Cancer; 1996 Jun; 32A(6):945-57. PubMed ID: 8763335
    [No Abstract]   [Full Text] [Related]  

  • 13. Importance of glutathione and associated enzymes in drug response.
    Shen H; Kauvar L; Tew KD
    Oncol Res; 1997; 9(6-7):295-302. PubMed ID: 9406235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug retention, efflux, and resistance in tumor cells.
    Krishan A; Fitz CM; Andritsch I
    Cytometry; 1997 Dec; 29(4):279-85. PubMed ID: 9415409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and reversal of multidrug resistance in paediatric cancers.
    Chan HS; Grogan TM; DeBoer G; Haddad G; Gallie BL; Ling V
    Eur J Cancer; 1996 Jun; 32A(6):1051-61. PubMed ID: 8763347
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular and pharmacological strategies to overcome multidrug resistance.
    Shabbits JA; Krishna R; Mayer LD
    Expert Rev Anticancer Ther; 2001 Dec; 1(4):585-94. PubMed ID: 12113091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutathione conjugates and their synthetic derivatives as inhibitors of glutathione-dependent enzymes involved in cancer and drug resistance.
    Burg D; Mulder GJ
    Drug Metab Rev; 2002 Nov; 34(4):821-63. PubMed ID: 12487151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multidrug-resistance by induction of inactivation for anti-cancer drugs].
    Ishii I; Kitada M
    Nihon Rinsho; 1997 May; 55(5):1044-9. PubMed ID: 9155150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolutionary malignant resistance of cells to damaging factors as common biological defence mechanism in neoplastic development. Review of conception.
    Monceviciute-Eringiene E
    J Exp Clin Cancer Res; 2000 Sep; 19(3):335-48. PubMed ID: 11144527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of multidrug resistance in oncology and hematology].
    Petrini M; Galimberti S
    Tumori; 1997; 83(5 Suppl):S17-20. PubMed ID: 9446254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.